Conjugates of Cryptophycin and RGD or isoDGR Peptidomimetics for Targeted Drug Delivery. Issue 6 (7th June 2019)
- Record Type:
- Journal Article
- Title:
- Conjugates of Cryptophycin and RGD or isoDGR Peptidomimetics for Targeted Drug Delivery. Issue 6 (7th June 2019)
- Main Title:
- Conjugates of Cryptophycin and RGD or isoDGR Peptidomimetics for Targeted Drug Delivery
- Authors:
- Borbély, Adina
Figueras, Eduard
Martins, Ana
Bodero, Lizeth
Raposo Moreira Dias, André
López Rivas, Paula
Pina, Arianna
Arosio, Daniela
Gallinari, Paola
Frese, Marcel
Steinkühler, Christian
Gennari, Cesare
Piarulli, Umberto
Sewald, Norbert - Abstract:
- Abstract: RGD‐cryptophycin and iso DGR‐cryptophycin conjugates were synthetized by combining peptidomimetic integrin ligands and cryptophycin, a highly potent tubulin‐binding antimitotic agent across lysosomally cleavable Val‐Ala or uncleavable linkers. The conjugates were able to effectively inhibit binding of biotinylated vitronectin to integrin αv β3, showing a binding affinity in the same range as that of the free ligands. The antiproliferative activity of the novel conjugates was evaluated on human melanoma cells M21 and M21‐L with different expression levels of integrin αv β3, showing nanomolar potency of all four compounds against both cell lines. Conjugates containing uncleavable linker show reduced activity compared to the corresponding cleavable conjugates, indicating efficient intracellular drug release in the case of cryptophycin‐based SMDCs. However, no significant correlation between the in vitro biological activity of the conjugates and the integrin αv β3 expression level was observed, which is presumably due to a non‐integrin‐mediated uptake. This reveals the complexity of effective and selective αv β3 integrin‐mediated drug delivery. Abstract : Successful delivery : Cryptophycin‐RGD/ iso DGR conjugates with lysosomally cleavable or uncleavable linkers display high binding affinity towards integrin αv β3 and show potent cytotoxicity in cell lines with different integrin expression levels.
- Is Part Of:
- ChemistryOpen. Volume 8:Issue 6(2019)
- Journal:
- ChemistryOpen
- Issue:
- Volume 8:Issue 6(2019)
- Issue Display:
- Volume 8, Issue 6 (2019)
- Year:
- 2019
- Volume:
- 8
- Issue:
- 6
- Issue Sort Value:
- 2019-0008-0006-0000
- Page Start:
- 737
- Page End:
- 742
- Publication Date:
- 2019-06-07
- Subjects:
- antitumor agents -- cancer -- drug delivery -- integrins -- peptidomimetics
Chemistry -- Periodicals
540
540.5 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)2191-1363 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1002/open.201900110 ↗
- Languages:
- English
- ISSNs:
- 2191-1363
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 25856.xml